Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Change in Cash (2014 - 2026)

Ocugen's (OCGN) quarterly Change in Cash came in at $13.3 million in Q1 2026, up 164.15% YoY from $5.0 million in Q1 2025, and up 194.96% on a QoQ basis from -$14.0 million in Q4 2025.

Analysis

Ocugen (OCGN) Change in Cash (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Change in Cash data on file, last reported at $13.3 million in Q1 2026.

  • Quarterly Change in Cash rose 164.15% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (down 150.59% YoY) and the FY2025 annual result came in at -$39.9 million, down 306.28% from the prior year.
  • Change in Cash climbed to $13.3 million in Q1 2026, from -$14.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $34.8 million in Q1 2022 to a low of -$24.0 million in Q4 2022.
  • A 5-year average of -$3.7 million and a median of -$10.8 million in 2025 frame the typical range for Change in Cash.
  • The widest YoY moves for Change in Cash: up 241.42% in 2024, down 547.43% in 2024.
  • Tracing OCGN's Change in Cash over 5 years: stood at -$24.0 million in 2022, then soared by 41.7% to -$14.0 million in 2023, then surged by 241.42% to $19.8 million in 2024, then sank by 170.59% to -$14.0 million in 2025, then jumped by 194.96% to $13.3 million in 2026.
  • The last three Change in Cash figures came in at $13.3 million (Q1 2026), -$14.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 68.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.20 Mn
Mar 31, 2026 13.29 Mn
Dec 31, 2025 -13.99 Mn
Sep 30, 2025 5.55 Mn
Jun 30, 2025 -10.79 Mn
Mar 31, 2025 -20.71 Mn
Dec 31, 2024 19.82 Mn
Sep 30, 2024 23.00 Mn
Jun 30, 2024 -10.38 Mn
Mar 31, 2024 -13.09 Mn
Dec 31, 2023 -14.02 Mn
Sep 30, 2023 -17.10 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 -9.30 Mn
Dec 31, 2022 -24.04 Mn
Sep 30, 2022 -13.40 Mn
Jun 30, 2022 -14.92 Mn
Mar 31, 2022 34.81 Mn
Dec 31, 2021 -12.39 Mn
Sep 30, 2021 -8.29 Mn